Interventional Oncology 2

Coordinator(s)

• PP

  Philippe Pereira, MD, PhD (he/him/his)

  Advisor
  SLK Kliniken gGmbH Heilbronn, Germany
• 

  Jordan Tasse, MD

  Associate professor of interventional radiology/Director of interventional oncology
  Rush University Medical Center, United States

Presentations:

• 9:45 AM - 9:54 AM ET

  Developing An Interventional Oncology Program: Strategies
  

  Speaker: Govindarajan Narayanan, MD, FSIR – Miami Cardiac & Vascular Institute
• 9:54 AM - 10:03 AM ET

  Fibrolamellar HCC: How is IR an Integral Part of Care
  

  Speaker: Jordan Tasse, MD – Rush University Medical Center
• 10:03 AM - 10:12 AM ET

  Integrating TACE, With (PD-[L]1 Inhibitors, and MTT In HCC
  

  Speaker: Hai-Dong Zhu, n/a – Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University
• 10:12 AM - 10:21 AM ET

  Ablation Vs Surgery: Dissecting COLLISION Study
  

  Speaker: Martijn Meijerink, MD, PhD – Amsterdam University Medical Center
• 10:21 AM - 10:30 AM ET

  IR's Growing Role and Integration Into Clinical Care in A Busy Cancer Hospital
  

  Speaker: Bela Kis, MD, PhD, FSIR (he/him/his) – Moffitt Cancer Center
• 10:35 AM - 10:45 AM ET

  HCC Management in A "Free Healthcare For All" System: Pros and Cons
• 10:39 AM - 10:48 AM ET

  topic coming soon - TBD
• 10:48 AM - 11:00 AM ET

  Q&A